We're closing out this year grateful to have spent 2023 in good company — with team members who continue to push the boundaries of science across various fields. We look forward to expanding the limits of drug discovery with scalable #proteomics & #massspectrometry in 2024!

Connect w/@AFederation & Lindsay Pino next week, Jan 8-12, at the SF Marriott Marquis for BIO's Partnering event at #JPMweek24. Reach out to learn how you can apply Talus Bio's technology to accelerate your company's #drugdiscovery efforts.

📢 Tomorrow UC Berkeley: Explore cutting-edge #chemoproteomics w/Talus Bio CTO Lindsay Pino, PhD, & @Bruker! Register for free here: bruker.com/en/landingpage…

While 1,700+ #transcriptionfactors (TFs) have been identified & 200 linked to cancer, *only 10 TFs* have approved drugs today. Combining new advances in scalable #proteomics & computational biology enables us to target the regulatory proteins driving a wide range of diseases.

Join us for this free virtual event tomorrow at 2PM PT: Biomedical Entrepreneurship & its Unique Challenges Talus Bio CEO & Co-founder Alex Federation will join life sciences leaders in a panel discussion led by ITHS: iths.org/event/biomedic… #biotech #lifesciences

Our resident platform integration expert Kyle Siebenthall heads to Boston Feb. 3-7 for #SLAS2024 — the premiere conference for the intersection of #drugdiscovery & lab automation. Reach out to Kyle if you're attending & would like to connect! #proteomics

Varun (the first author) was one of our interns last summer Talus Bio 🙌

#WorldCancerDay: Access to life saving & life-extending #cancer treatments should be equitable for all. We're working to close the treatment gap for hard-to-treat cancers linked to #transcriptionfactor dysregulation. You can take action at worldcancerday.org

Data drives discovery at Talus Bio. Here's how we integrate the best in science & technology for effective & efficient transcription factor drug discovery ⬇️ #proteomics #transcriptionfactors #drugdiscovery #teammassspec

Attending #USHUPO next month in Portland? Here's a sampling of the latest functional proteomics work being presented by Talus Bio's Lindsay Pino, Ph.D. Lindsay K Pino - @[email protected], Will Fondrie, Ph.D. Will Fondrie, and Bodhi Hueffmeier ⬇️ This will be the biggest USHUPO ever: loom.ly/DfKtIvk

VibeCast Episode 47 w/ Dr. Alex Federation, CEO & Co-Founder of Talus Bio, is now live! In this episode w/ host Ray @ Health Unchained, we discuss leveraging machine learning to unlock the potential of the undruggable genome for therapies🧬 Full episode here: youtu.be/K9be_3rD7E4

With $11.2M in new funding led by @twobearcapital, Talus Bio is set to revolutionize the way we approach drug discovery. Our MARMOT platform is using proteomics and AI to lead the charge against previously "undruggable" transcription factors. Game On! fiercebiotech.com/biotech/talus-…

We’re proud to welcome Gaelle Mercenne, PhD to Talus Bio as our new Head of Biology. A pioneer at the forefront of AI-accelerated drug discovery, she brings the deep expertise necessary to expand our pipeline of transcription factor therapeutics. See more bit.ly/4gTxa06

Meet our new Head of Biology, Gaelle Mercenne, featured in STAT by @EdSilverman. He asked her what piece of lab equipment she’d be, find out when you read the whole conversation in Ed’s “Up & Down the Ladder” for STAT 🔽 bit.ly/3U5rKoX

Congratulations to our co-founder and CTO, Lindsay Pino, for receiving the Rising Star Award from Human Proteome! Her outstanding contributions in research, entrepreneurship and community engagement have expanded the field & breadth of new discovery in proteomics. Well done, Lindsay!

Where would genomics be if the BAM/SAM file format was proprietary and Bamtools/Bowtie was closed source and prohibitively expensive? That's where the proteomics field is right now. Talus Bio's Will Fondrie and a group of industry+academia leaders share: go.shr.lc/3B7rRtW

How should we think about rare disease drug discovery in today’s economy? I looked at how Syndax is approaching their new Menin inhibitors as an example

80 Startups Building the Future 🧬 🧬 — and they'll be at #SynBioBeta2025! check 'em out below: syntheticbiologysummit.com A-Alpha Bio , Allozymes , Ample Agriculture, Anthology Bio, Apasomics, Corp. , Atom Bioworks , Baobab Laboratories, Berkeley Pharma Tech Tech, Biomatter ,

Can't wait!

Are you working at the frontier of biology? We’re looking for a few fellow explorers to map the regulome together. The Talus Bio Regulome Early Access Program opens today, join us in charting the cell’s decision-making system in real time. We’ll work side by side to deploy the